return to news
  1. Sudeep Pharma IPO subscribed 4.08 times so far on Day 2: Check price band, lot size and financials

Market News

Sudeep Pharma IPO subscribed 4.08 times so far on Day 2: Check price band, lot size and financials

Kamal Joshi

3 min read | Updated on November 24, 2025, 14:48 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Sudeep Pharma IPO: The ₹895 crore initial share sale has set a price band of ₹563 to ₹593 per equity share. A lot consists of 25 shares and multiples thereof.

Sudeep Pharma IPO will conclude on November 25. | Image: LinkedIn/Sudeep Pharma

Sudeep Pharma IPO will conclude on November 25. | Image: LinkedIn/Sudeep Pharma

Sudeep Pharma IPO: The initial public offer of Sudeep Pharma Ltd has been subscribed 4.08 times so far on the second day of share sale on Monday, November 24.

Open FREE Demat Account within minutes!
Join now

The IPO received bids for 4,31,02,900 shares compared to 1,05,64,926 shares on offer, according to the National Stock Exchange (NSE) data.

The quota for non-institutional investors (NIIs) attracted 9.10 times the subscription, while the category for retail individual investors (RIIs) got subscribed 4.20 times. The part for qualified institutional buyers (QIBs) fetched 11% subscription.

The ₹895 crore initial share sale, which will conclude on November 25, has set a price band of ₹563 to ₹593 per equity share. A lot consists of 25 shares.

The IPO is a fresh issue of shares valued at ₹95 crore and an offer-for-sale (OFS) aggregating to ₹800 crore by the promoters Sujit Jaysukh Bhayani, Shanil Sujit Bhayani, Avani Sujit Bhayani and Sujeet Jaysukh Bhayani HUF.

Fresh issue proceeds to the tune of ₹75.81 crore will be utilised for capital expenditure towards the procurement of machinery for its production line located at Gujarat's Nandesari Facility 1 and for general corporate purposes.

The company's shares will be listed on the stock exchanges on November 28.

Sudeep Pharma IPO GMP

According to media reports and investorgain.com, the unlisted shares of Sudeep Pharma are trading at ₹707, reflecting a grey market premium of 19.22% over the upper price band of ₹593.

Disclaimer: Grey Market Premium (GMP) is not regulated or recommended by the stock exchanges or SEBI. Upstox does not endorse or facilitate trading in the grey market. Investors are advised to conduct their own research or consult an expert before making any investment decisions.

About the company

Sudeep Pharma is a technology-led manufacturer of excipients and speciality ingredients for the pharma, food, and nutrition industries, dedicated to contributing to the global healthcare ecosystem.

The company is one of the largest producers of food-grade iron phosphate for infant nutrition, clinical nutrition, and the food and beverage sectors, in terms of production capacity. It is a key exporter of mineral ingredients for food, pharmaceutical and nutrition applications.

Sudeep Pharma IPO financials

(₹ crore)FY 23FY 24FY 25
Revenue428.74459.28501.99
Total Assets420.11513.87717.17
Net Profit62.32133.19138.69
EBITDA98.64187.75199.28
To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.

To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Kamal Joshi
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing tennis, especially flexing his backhand. He was previously associated with Republic TV and LatestLY.

Next Story